Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population.

World journal of gastroenterology - 1 Jul 2004

Shi Wei-Xing, Chen Shu-Qing

Abstract excerpt

AIM: To investigate the association between cytochrome P450 2C19 (CYP2C19) gene polymorphism and cancer susceptibility by genotyping of CYP2C19 poor metabolizers (PMs) in cancer patients. METHODS: One hundred and thirty-five cases of esophagus cancer, 148 cases of stomach cancer, 212 cases of lung cancer, 112 cases of bladder cancer and 372 controls were genotyped by allele specific amplification-polymerase chain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Esophageal Neoplasms

Share to Incidence

Share to Mixed Function Oxygenases

Share to Neoplasms

Share to Stomach Neoplasms

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 15222046
DOI: 10.3748/wjg.v10.i13.463
PMCID: PMC4572240

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population.PMID 15222046Read ↗

Poor metabolizers at the cytochrome P450 2C19 loci is at increased risk of developing cancer in Asian populations.Semantic proximity Read ↗

Functional polymorphisms in the CYP2C19 gene contribute to digestive system cancer risk: evidence from 11,042 subjects.Semantic proximity Read ↗

Quantitative assessment of the influence of cytochrome P450 2C19 gene polymorphisms and digestive tract cancer risk.Semantic proximity Read ↗

A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer.Semantic proximity Read ↗

Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection.Semantic proximity Read ↗

CYP2C19 polymorphisms in patients with gastric and colorectal carcinoma.Semantic proximity Read ↗

CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high- incidence area in north China.Semantic proximity Read ↗

Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response.Semantic proximity Read ↗

A rapid and simple detection of genetic defects responsible for the phenotypic polymorphism of cytochrome P450 2C19.Semantic proximity Read ↗

Single-nucleotide polymorphism in CYP1A1, CYP1B1, CYP2B6, CYP2C8, and CYP2C9 genes and their association with gastrointestinal cancer: A hospital-based case-control study.Semantic proximity Read ↗

The association of CYP2C9 gene polymorphisms with colorectal carcinoma in Han Chinese.Semantic proximity Read ↗

Association of Genetic Variants of CYP2C19 and CYP2D6 with Esophageal Squamous Cell Carcinoma Risk in Northern India, Kashmir.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.